Literature DB >> 2692646

Regulation of human breast cancer by secreted growth factors.

K J Cullen1, D Yee, S E Bates, N Brunner, R Clarke, R E Dickson, K K Huff, S Paik, N Rosen, E Valverius.   

Abstract

Laboratory evidence is presented that estrogens are able to induce the production of numerous growth factors which can act in an autocrine or paracrine fashion in estrogen dependent breast cancer. Estrogen independent tumors can produce these same growth factors constitutively and so escape the need for estrogen stimulation. Growth inhibitory factors such as TGF-beta can also be controlled by estrogens and antiestrogens. It is unclear at present, however, how much of the cytostatic effect of antiestrogens in vivo is explained by the production of growth inhibitors. The overall control of breast cancer growth is mediated by the combined effects of these growth stimulatory and inhibitory factors in both breast stroma and epithelium. Interruption of the action of growth factors and the use of growth inhibitors may provide opportunities for new approaches to the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692646     DOI: 10.3109/02841868909092318

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  10 in total

1.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.

Authors:  P G Gill; W D Tilley; N J De Young; I L Lensink; P D Dixon; D J Horsfall
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

Review 3.  Regulation of insulin-like growth factors by antiestrogen.

Authors:  R Winston; P C Kao; D T Kiang
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.

Authors:  A de Cupis; P Pirani; L Fazzuoli; R E Favoni
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Nov-Dec       Impact factor: 2.416

5.  Activation of autophagy in mesenchymal stem cells provides tumor stromal support.

Authors:  Cecilia G Sanchez; Patrice Penfornis; Adam Z Oskowitz; Aaron G Boonjindasup; David Z Cai; Santosh S Dhule; Brian G Rowan; Ameeta Kelekar; Diane S Krause; Radhika R Pochampally
Journal:  Carcinogenesis       Date:  2011-02-11       Impact factor: 4.944

6.  Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.

Authors:  A de Cupis; D Noonan; P Pirani; A Ferrera; L Clerico; R E Favoni
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Clinical breast cancer research core.

Authors:  S M Swain; S F Honig; E Egan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.

Authors:  Dana L Felice; Lamiaa El-Shennawy; Shuangping Zhao; Daniel L Lantvit; Qi Shen; Terry G Unterman; Steven M Swanson; Jonna Frasor
Journal:  Endocrinology       Date:  2013-06-19       Impact factor: 4.736

9.  Fibroblast stimulation of breast cancer cell growth in a serum-free system.

Authors:  M C Ryan; D J Orr; K Horgan
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

10.  Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen.

Authors:  A J Stewart; B R Westley; F E May
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.